Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease

Marissa J. Schafer, Elizabeth J. Atkinson, Patrick M. Vanderboom, Brian Kotajarvi, Thomas A. White, Matthew M. Moore, Charles J Bruce, Kevin L. Greason, Rakesh M. Suri, Sundeep Khosla, Jordan D Miller, Harold Robert (Bob) III Bergen, Nathan K LeBrasseur

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Growth and differentiation factor 11 (GDF11) is a transforming growth factor β superfamily member with a controversial role in aging processes. We have developed a highly specific LC-MS/MS assay to quantify GDF11, resolved from its homolog, myostatin (MSTN), based on unique amino acid sequence features. Here, we demonstrate that MSTN, but not GDF11, declines in healthy men throughout aging. Neither GDF11 nor MSTN levels differ as a function of age in healthy women. In an independent cohort of older adults with severe aortic stenosis, we show that individuals with higher GDF11 were more likely to be frail and have diabetes or prior cardiac conditions. Following valve replacement surgery, higher GDF11 at surgical baseline was associated with rehospitalization and multiple adverse events. Cumulatively, our results show that GDF11 levels do not decline throughout aging but are associated with comorbidity, frailty, and greater operative risk in older adults with cardiovascular disease.

Original languageEnglish (US)
Pages (from-to)1207-1215
Number of pages9
JournalCell Metabolism
Volume23
Issue number6
DOIs
StatePublished - Jun 14 2016

Fingerprint

Growth Differentiation Factors
Myostatin
Cardiovascular Diseases
Aortic Valve Stenosis
Transforming Growth Factors
Comorbidity
Amino Acid Sequence

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Physiology

Cite this

Schafer, M. J., Atkinson, E. J., Vanderboom, P. M., Kotajarvi, B., White, T. A., Moore, M. M., ... LeBrasseur, N. K. (2016). Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease. Cell Metabolism, 23(6), 1207-1215. https://doi.org/10.1016/j.cmet.2016.05.023

Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease. / Schafer, Marissa J.; Atkinson, Elizabeth J.; Vanderboom, Patrick M.; Kotajarvi, Brian; White, Thomas A.; Moore, Matthew M.; Bruce, Charles J; Greason, Kevin L.; Suri, Rakesh M.; Khosla, Sundeep; Miller, Jordan D; Bergen, Harold Robert (Bob) III; LeBrasseur, Nathan K.

In: Cell Metabolism, Vol. 23, No. 6, 14.06.2016, p. 1207-1215.

Research output: Contribution to journalArticle

Schafer, MJ, Atkinson, EJ, Vanderboom, PM, Kotajarvi, B, White, TA, Moore, MM, Bruce, CJ, Greason, KL, Suri, RM, Khosla, S, Miller, JD, Bergen, HRBIII & LeBrasseur, NK 2016, 'Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease', Cell Metabolism, vol. 23, no. 6, pp. 1207-1215. https://doi.org/10.1016/j.cmet.2016.05.023
Schafer MJ, Atkinson EJ, Vanderboom PM, Kotajarvi B, White TA, Moore MM et al. Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease. Cell Metabolism. 2016 Jun 14;23(6):1207-1215. https://doi.org/10.1016/j.cmet.2016.05.023
Schafer, Marissa J. ; Atkinson, Elizabeth J. ; Vanderboom, Patrick M. ; Kotajarvi, Brian ; White, Thomas A. ; Moore, Matthew M. ; Bruce, Charles J ; Greason, Kevin L. ; Suri, Rakesh M. ; Khosla, Sundeep ; Miller, Jordan D ; Bergen, Harold Robert (Bob) III ; LeBrasseur, Nathan K. / Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease. In: Cell Metabolism. 2016 ; Vol. 23, No. 6. pp. 1207-1215.
@article{6d9fbf78e78e4a22a5d33d76b1cd4661,
title = "Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease",
abstract = "Growth and differentiation factor 11 (GDF11) is a transforming growth factor β superfamily member with a controversial role in aging processes. We have developed a highly specific LC-MS/MS assay to quantify GDF11, resolved from its homolog, myostatin (MSTN), based on unique amino acid sequence features. Here, we demonstrate that MSTN, but not GDF11, declines in healthy men throughout aging. Neither GDF11 nor MSTN levels differ as a function of age in healthy women. In an independent cohort of older adults with severe aortic stenosis, we show that individuals with higher GDF11 were more likely to be frail and have diabetes or prior cardiac conditions. Following valve replacement surgery, higher GDF11 at surgical baseline was associated with rehospitalization and multiple adverse events. Cumulatively, our results show that GDF11 levels do not decline throughout aging but are associated with comorbidity, frailty, and greater operative risk in older adults with cardiovascular disease.",
author = "Schafer, {Marissa J.} and Atkinson, {Elizabeth J.} and Vanderboom, {Patrick M.} and Brian Kotajarvi and White, {Thomas A.} and Moore, {Matthew M.} and Bruce, {Charles J} and Greason, {Kevin L.} and Suri, {Rakesh M.} and Sundeep Khosla and Miller, {Jordan D} and Bergen, {Harold Robert (Bob) III} and LeBrasseur, {Nathan K}",
year = "2016",
month = "6",
day = "14",
doi = "10.1016/j.cmet.2016.05.023",
language = "English (US)",
volume = "23",
pages = "1207--1215",
journal = "Cell Metabolism",
issn = "1550-4131",
publisher = "Cell Press",
number = "6",

}

TY - JOUR

T1 - Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease

AU - Schafer, Marissa J.

AU - Atkinson, Elizabeth J.

AU - Vanderboom, Patrick M.

AU - Kotajarvi, Brian

AU - White, Thomas A.

AU - Moore, Matthew M.

AU - Bruce, Charles J

AU - Greason, Kevin L.

AU - Suri, Rakesh M.

AU - Khosla, Sundeep

AU - Miller, Jordan D

AU - Bergen, Harold Robert (Bob) III

AU - LeBrasseur, Nathan K

PY - 2016/6/14

Y1 - 2016/6/14

N2 - Growth and differentiation factor 11 (GDF11) is a transforming growth factor β superfamily member with a controversial role in aging processes. We have developed a highly specific LC-MS/MS assay to quantify GDF11, resolved from its homolog, myostatin (MSTN), based on unique amino acid sequence features. Here, we demonstrate that MSTN, but not GDF11, declines in healthy men throughout aging. Neither GDF11 nor MSTN levels differ as a function of age in healthy women. In an independent cohort of older adults with severe aortic stenosis, we show that individuals with higher GDF11 were more likely to be frail and have diabetes or prior cardiac conditions. Following valve replacement surgery, higher GDF11 at surgical baseline was associated with rehospitalization and multiple adverse events. Cumulatively, our results show that GDF11 levels do not decline throughout aging but are associated with comorbidity, frailty, and greater operative risk in older adults with cardiovascular disease.

AB - Growth and differentiation factor 11 (GDF11) is a transforming growth factor β superfamily member with a controversial role in aging processes. We have developed a highly specific LC-MS/MS assay to quantify GDF11, resolved from its homolog, myostatin (MSTN), based on unique amino acid sequence features. Here, we demonstrate that MSTN, but not GDF11, declines in healthy men throughout aging. Neither GDF11 nor MSTN levels differ as a function of age in healthy women. In an independent cohort of older adults with severe aortic stenosis, we show that individuals with higher GDF11 were more likely to be frail and have diabetes or prior cardiac conditions. Following valve replacement surgery, higher GDF11 at surgical baseline was associated with rehospitalization and multiple adverse events. Cumulatively, our results show that GDF11 levels do not decline throughout aging but are associated with comorbidity, frailty, and greater operative risk in older adults with cardiovascular disease.

UR - http://www.scopus.com/inward/record.url?scp=84975483043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975483043&partnerID=8YFLogxK

U2 - 10.1016/j.cmet.2016.05.023

DO - 10.1016/j.cmet.2016.05.023

M3 - Article

C2 - 27304512

AN - SCOPUS:84975483043

VL - 23

SP - 1207

EP - 1215

JO - Cell Metabolism

JF - Cell Metabolism

SN - 1550-4131

IS - 6

ER -